GoodRx Holdings, Inc. (GDRX) August 7.5 straddle priced for a move of 23% into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 4c, Offers Guidance
August 8, 2022 4:23 PM EDTGoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.00, $0.04 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $191.8 million versus the consensus estimate of $185.36 million.
GUIDANCE:
GoodRx Holdings, Inc. sees Q3 2022 revenue of $185 million, versus the... More
